Analysis
Three reported deals in this issue's funding section total roughly $625 million in disclosed capital:
- Island -- $400M Series F at a $6.4B valuation: AI-agent and enterprise browser security.
- Brahma AI -- $150M round at a $2B valuation: enterprise AI for media, sports and healthcare content.
- BigHat Biosciences -- $75M Series C, $223M total raised: AI-designed antibody therapeutics.
The rest of this issue's funding section looks at the broader pattern behind those three deals: a wave of $1 billion-plus mega-rounds and a rebound in digital-health financing, both detailed elsewhere in this section.
“- Island -- $400M Series F at a $6.4B valuation: AI-agent and enterprise browser security.”
The broader 2026 numbers back up that concentration. Pulse's own tracking shows:
- AI infrastructure: $17.77B across 37 disclosed deals since August 2025 (average round above $480M), per sector tracking cited by newmarketpitch.com.
- Robotics: a record $18.8B raised in 2026, per Crunchbase News.
- Defense tech: 107 venture rounds in 2026, ahead of 2025's pace.
- Digital health: $7.4B raised in H1 2026, per Fierce Healthcare, after a multi-year drought.
None of this means every AI-adjacent startup is getting funded easily -- round sizes for newer, less proven categories remain a fraction of the mega-rounds going to hardware- or infrastructure-heavy plays with government- or hyperscaler-scale contracts already in hand. The gap is mostly one of contract size and capital intensity, not conviction.